Ardelyx Inc (ARDX)

6.43 +0.04 (+0.63%) USD  |  NASDAQ  |  Apr 24, 16:00
6.435 0.00 (0.00%) After-Hours: 20:00
More

Ardelyx Cash and Short Term Investments (Quarterly): 184.30M for Dec. 31, 2023

Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2013. Upgrade now.
Date Value
December 31, 2023 184.30M
September 30, 2023 165.08M
June 30, 2023 127.58M
March 31, 2023 130.37M
December 31, 2022 123.91M
September 30, 2022 90.62M
June 30, 2022 81.01M
March 31, 2022 89.70M
December 31, 2021 116.69M
September 30, 2021 141.65M
June 30, 2021 171.81M
March 31, 2021 178.21M
December 31, 2020 186.48M
September 30, 2020 185.50M
June 30, 2020 204.84M
March 31, 2020 223.21M
December 31, 2019 247.51M
September 30, 2019 103.54M
June 30, 2019 123.94M
March 31, 2019 151.56M
December 31, 2018 168.09M
Date Value
September 30, 2018 186.41M
June 30, 2018 212.73M
March 31, 2018 127.45M
December 31, 2017 133.98M
September 30, 2017 129.29M
June 30, 2017 148.72M
March 31, 2017 173.42M
December 31, 2016 200.82M
September 30, 2016 230.09M
June 30, 2016 146.67M
March 31, 2016 171.68M
December 31, 2015 107.00M
September 30, 2015 129.05M
June 30, 2015 141.53M
March 31, 2015 98.32M
December 31, 2014 107.29M
September 30, 2014 112.04M
June 30, 2014 117.81M
March 31, 2014 33.22M
December 31, 2013 34.44M

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

81.01M
Minimum
Jun 2022
247.51M
Maximum
Dec 2019
151.37M
Average
141.65M
Median
Sep 2021

Cash and Short Term Investments (Quarterly) Benchmarks

Nektar Therapeutics 303.62M
Omeros Corp 171.85M
Vistagen Therapeutics Inc 126.56M
Karyopharm Therapeutics Inc 191.44M
Adverum Biotechnologies Inc 96.53M